J4 ›› 2010, Vol. 36 ›› Issue (1): 127-130.

• 基础研究 • 上一篇    下一篇

3|4|5-三羟基苯甲酸对H22肝癌小鼠实体瘤的抑制作用及其机制

赵文静1,2|牛凤兰1|刘作家1|郗艳丽1|李广益1   

  1. 1.吉林大学公共卫生学院卫生检验学教研室|吉林 长春 130021;2.吉林省肝胆病医院科研室|吉林 长春 130062
  • 收稿日期:2009-07-23 出版日期:2010-01-28 发布日期:2010-01-28
  • 通讯作者: 牛凤兰(Tel:0431-85619133, E-mail:jluniu@yahoo.com.cn) E-mail:jluniu@yahoo.com.cn
  • 作者简介:赵文静(1973-) |女|吉林省吉林市人|副主任技师|医学博士|主要从事天然产物活性成分与健康研究。
  • 基金资助:

    吉林省科技厅重点项目资助课题(20070424);吉林省高薪产业公关项目资助课题(20051564)

Inhibitory effects of 3|4|5-TBA on H22 tumor bearing mice and mechanism

 ZHAO Wen-Jing1,2, NIU Feng-Lan1, LIU Zuo-Jia1, XI Yan-Li1, LI Guang-Yi1   

  1. 1.Department of Health Laboratory,School of Public Health,Jilin University,Changchun 130021|China;2.Department of Scientific Research,Hospital of Hepatobiliary Disease,Jilin Province, Changchun 130062,China
  • Received:2009-07-23 Online:2010-01-28 Published:2010-01-28

摘要:

目的:观察3,4,5-三羟基苯甲酸(TBA)对H22肝癌小鼠实体瘤的抑制作用及其对荷瘤小鼠生存时间和体内抗氧化能力的影响。方法:建立移植性H22肝癌细胞荷瘤小鼠模型,造模成功小鼠随机分为空白对照组,阳性药对照组,TBA低、中、高剂量组;每组10只。对照组0.5% 羧甲基纤维素钠溶液0.2 mL·10 g-1灌胃给药,阳性药对照组CTX 20 mg·kg-1腹腔注射,TBA低、中、高剂量组TBA溶液0.13、0.25 和0.50 g·kg-1灌胃给药,每天固定时间给药1次,连续给药10 d。检测各组小鼠实体瘤质量、小鼠生存时间、血清超氧化物歧化酶(SOD)活性、丙二醛(MDA)和还原型谷胱甘肽(GSH)水平。结果:与空白对照组比较,TBA中剂量组和CTX阳性药对照组小鼠平均瘤质量下降(P<0.05),其他各组间比较差异无显著性;与空白对照组比较,TBA中剂量组和CTX阳性药对照组小鼠平均生存时间延长(P<0.05),其他各组间比较差异无显著性;与空白对照组比较,TBA中、高剂量组小鼠血清SOD活性升高(P<0.05),中剂量组血清MDA 水平降低(P<0.05),低、中、高剂量组血清GSH升高(P<0.05),其他各组间比较差异无显著性。结论:TBA灌胃给药可以不同程度抑制H22 肿瘤的生长,延长荷瘤小鼠生存时间;TBA可以清除荷瘤小鼠体内自由基,上调机体的氧化应激状态。

关键词: 3,4,5-三羟基苯甲酸;抗肿瘤药;抗氧化剂

Abstract:

Abstract:Objective  To observe the inhibitory effect of 3,4,5-hydroxy benzoic acid (TBA) on H22 transplanted tumor in mice and  its influence in survival time and antioxidant capacity in vivo of H22 tumor bearing mice .Methods H22  tumor bearing mouse models were established.The H22 tumor bearing mice were randomly divided into  control group,positive control group,TBA low dose group,TBA middle dose group,and TBA high dose group.There were 10 mice in each group.0.5% sodium carboxymethyl cellulose solution 2 mL·10 g-1 was administered by oral in control group.CTX 20 mg·kg-1 was injected intraperitoneally in positive control group.TBA was administered by oral in TBA low (0.13 g·kg-1),middle(0.25 g·kg-1) and high(0.50 g·kg-1)dose groups.The H22  tumor bearing mice were administered once a day at fixed time and  lasted  for 10 d.Then,the tumor  weight,the survival time,and  the SOD activity,MDA and GSH levels in serum in each group were detected.Results Compared with control group,the average tumor weights were  reduced in TBA middle dose group and CTX group (P<0.05),there was no significant difference between other groups;compared with control group,the mean survival time in TBA middle dose group and CTX group  were longer (P<0.05),there was no significant difference between other groups;compared with control group,the SOD activities  in TBA middle and high dose groups were significantly increased(P<0.05);the MDA level  in TBA middle dose group was significantly decreased(P<0.05);the GSH levels were in TBA low,middle,high dose groups were significantly increased(P<0.05). Conclusion  TBA could inhibit the growth of H22  tumor  and prolong the survival time of tumor bearing mice by oral administration. TBA could clear the free radicals in tumor bearing mice and up-regulate the  oxidative stress status of body.

Key words: 3,4,5-trihydroxybenzoic acid;antineoplastic agents;antioxidants

中图分类号: 

  • R735.7